SRPT
#2027
Sarepta Therapeutics, Inc. - Common Stock
17.9 6 USD
-0.05%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-4.57%
Monthly Change
+13.89%
6 month change
-15.36%
Year Change
-1.86%
Previous Close
18.8 2
Open
17.9 6
Low
17.9 6
High
17.9 6
Volume
206
Financials
- Market Capitalization 1.9 B
- Employee 835
- Founded 1980
- CEO Douglas S. Ingram
- Website www.sarepta.com
- Headquarter Delaware, United States
- FIGI BBG000BCJ161
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-22.67
Price to sales ratio
1.08
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2012 |  SION Sionna Therapeutics, Inc. - Common Stock | 42.59 USD | -3.09% | -4.25% | +18.27% | +8.26% | 1.92 B USD | ||
| 2025 |  URGN UroGen Pharma Ltd. - Ordinary Shares | 39.19 USD | -0.81% | +4.87% | +27.86% | +106.26% | 1.91 B USD | ||
| 2040 |  NTLA Intellia Therapeutics, Inc. - Common Stock | 13.30 USD | +2.15% | -20.88% | -9.95% | -3.06% | 1.86 B USD | ||
| 2046 |  BCAX Bicara Therapeutics Inc. - Common Stock | 28.10 USD | -0.18% | -6.05% | +30.58% | +94.60% | 1.85 B USD |
Frequently asked questions about Sarepta Therapeutics, Inc. - Common Stock
What is the Sarepta Therapeutics, Inc. - Common Stock stock price today?
The current price of Sarepta Therapeutics, Inc. - Common Stock (SRPT) is 17.96. Over the past 24 hours, the stock has changed by -4.57%. Follow the SRPT chart for real-time price dynamics.
What is the stock ticker of Sarepta Therapeutics, Inc. - Common Stock?
Sarepta Therapeutics, Inc. - Common Stock trades under the ticker SRPT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Sarepta Therapeutics, Inc. - Common Stock stock going up?
SRPT has changed by -8.97% over the last week, +13.89% over the last month, and -1.86% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Sarepta Therapeutics, Inc. - Common Stock net income for the last quarter?
Sarepta Therapeutics, Inc. - Common Stock reported net income of 330.96 M for the last quarter. The previous quarter showed -412.23 M, which means net income changed by +180.29%.
How many employees does Sarepta Therapeutics, Inc. - Common Stock have?
As of the latest available data, Sarepta Therapeutics, Inc. - Common Stock has 835 employees. Workforce size can provide additional context about the company's scale and operations.
What is Sarepta Therapeutics, Inc. - Common Stock EBITDA?
Sarepta Therapeutics, Inc. - Common Stock EBITDA is 369.03 M, and its EBITDA margin is 50.5%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Sarepta Therapeutics, Inc. - Common Stock stock?
You can buy Sarepta Therapeutics, Inc. - Common Stock (SRPT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Sarepta Therapeutics, Inc. - Common Stock stock?
Investing in Sarepta Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SRPT chart and related analysis on metatrader.com as part of your research.